NCT00004387View on ClinicalTrials.gov

Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 1996

Conditions
Parkinson Disease
Interventions
PROCEDURE

fetal nigral transplantation

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004387 - Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter